Alembic Pharmaceuticals Limited

₹1,010As of Sun 8 Nov 2026, 12:00 UTC
NSE:APLLTDHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 5.47%
Div yield 1.19%
ROE 14.93%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.34
PE TTM 23.52
TSR TTM 14.22%
Mkt cap ₹198.5B
ROIC 13.45%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,169
15.79%
(94.60%)
Hold 2|11|1|11|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
8.49
8.60
8.84
8.80
1.16%
7.66%
12.57%
3.40%
Revenue₹B
24.42
24.77
24.30
23.71
5.37%
6.93%
0.28%
(0.49%)
Peers (US$2.016B)
Cap (US$)
PE
2.100B
27.85x
Capital
TTM
5Y
10Y
Leveragex
0.143
0.016
0.016
EBIT/Intx
0.377
0.198
0.202
Own earn%
(951.99)
105.27
83.30
Sh yield%
25.71
34.18
33.85
Owners
Insiders/Inst%
8.87
63.64
Short interest%
3.01
SBC / revenue%
5.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
8–12
$1 testx
0.0
Incr. ROIC%
4